YDES YD Bio Limited - Ordinary Shares
YDES Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
YDES Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| YDES | — | — | — | — | — | — |
| MENS | — | — | — | — | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 12 filers · $626K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 4 (+4 vs prior Q) | 0 (-2 vs prior Q) | 4 (-1 vs prior Q) | 1 (0 vs prior Q) | +119K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Garrett Wealth Advisory Group, LLC | $190,418 | 84,630 | 30.42% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $141,106 | 62,714 | 22.54% | Shares |
| Cypress Capital Management LLC (WY) | $75,803 | 33,690 | 12.11% | Shares |
| Cerity Partners LLC | $72,914 | 32,406 | 11.65% | Shares |
| CITADEL ADVISORS LLC | $67,739 | 30,106 | 10.82% | Shares |
| JANE STREET GROUP, LLC | $39,218 | 17,430 | 6.27% | Shares |
| UBS Group AG | $27,432 | 12,192 | 4.38% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $10,994 | 4,886 | 1.76% | Shares |
| WELLS FARGO & COMPANY/MN | $169 | 75 | 0.03% | Shares |
| MORGAN STANLEY | $108 | 48 | 0.02% | Shares |
| FMR LLC | $2 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 117 | 0.00% | Shares |
Company insiders 2 insiders · 0 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Kochi Chang | Director | March 31, 2026 M | 2,081 | 0 | 0 | $0 |
| Shao-Ta Lu | Director | March 31, 2026 M | 2,081 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only